Canonical: https://ownershiptrace.com/13f/companies/2470

# Who owns NewAmsterdam Pharma Co N.V. (NAMS)? Elite investor 13F holders

4 tracked elite investors reported holding NewAmsterdam Pharma Co N.V as of 2026-06-30, including Viking Global Investors, Maverick Capital, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Viking Global Investors](https://ownershiptrace.com/13f/investors/81) | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 142458886.00 USD | 4203567.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1103804/0001103804-26-000006-index.html) |
| [Maverick Capital](https://ownershiptrace.com/13f/investors/50) | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 110745810.00 USD | 3267802.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/934639/0000947871-26-000793-index.html) |
| [Duquesne Family Office](https://ownershiptrace.com/13f/investors/30) | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1536411/0001536411-26-000006-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4085812.00 USD | 120561.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | Newamsterdam Pharma Company | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2692899.00 USD | 79460.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)